| Parkinson’s disease: etiology, neuropathology, and pathogenesis A Kouli, KM Torsney, WL Kuan Exon Publications, 3-26, 2018 | 551 | 2018 |
| Cerebrovascular and blood–brain barrier impairments in Huntington's disease: potential implications for its pathophysiology J Drouin‐Ouellet, SJ Sawiak, G Cisbani, M Lagacé, WL Kuan, ... Annals of neurology 78 (2), 160-177, 2015 | 259 | 2015 |
| Intracellular SERS nanoprobes for distinction of different neuronal cell types A Huefner, WL Kuan, RA Barker, S Mahajan Nano letters 13 (6), 2463-2470, 2013 | 162 | 2013 |
| Parkinson’s disease: pathogenesis and clinical aspects A Kouli, KM Torsney, WL Kuan, TB Stoker, JC Greenland Parkinson’s disease: pathogenesis and clinical aspects. Codon Publications …, 2018 | 110 | 2018 |
| Characterization and visualization of vesicles in the endo-lysosomal pathway with surface-enhanced Raman spectroscopy and chemometrics A Huefner, WL Kuan, KH Müller, JN Skepper, RA Barker, S Mahajan ACS nano 10 (1), 307-316, 2016 | 96 | 2016 |
| Gold nanoparticles explore cells: Cellular uptake and their use as intracellular probes A Huefner, D Septiadi, BD Wilts, II Patel, WL Kuan, A Fragniere, ... Methods 68 (2), 354-363, 2014 | 87 | 2014 |
| Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease RS Wijeyekoon, D Kronenberg-Versteeg, KM Scott, S Hayat, WL Kuan, ... Brain, behavior, and immunity 87, 473-488, 2020 | 65 | 2020 |
| GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain GH Dar, CC Mendes, WL Kuan, AA Speciale, M Conceição, A Görgens, ... Nature communications 12 (1), 6666, 2021 | 57 | 2021 |
| α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function WL Kuan, N Bennett, X He, JN Skepper, N Martynyuk, R Wijeyekoon, ... Experimental neurology 285, 72-81, 2016 | 55 | 2016 |
| The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson’s disease, and the effect of chronic treatment with the selective … WL Kuan, JW Zhao, RA Barker Psychopharmacology 197, 279-293, 2008 | 50 | 2008 |
| New therapeutic approaches to Parkinson’s disease including neural transplants WL Kuan, RA Barker Neurorehabilitation and neural repair 19 (3), 155-181, 2005 | 46 | 2005 |
| The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias WL Kuan, R Lin, P Tyers, RA Barker Neurobiology of disease 25 (3), 594-608, 2007 | 43 | 2007 |
| Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease A Huefner, WL Kuan, SL Mason, S Mahajan, RA Barker Chemical Science 11 (2), 525-533, 2020 | 41 | 2020 |
| A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial complex I activity WL Kuan, E Poole, M Fletcher, S Karniely, P Tyers, M Wills, RA Barker, ... Journal of Experimental Medicine 209 (1), 1-10, 2012 | 39 | 2012 |
| Graft-induced dyskinesias in Parkinson's disease: what is it all about? RA Barker, WL Kuan Cell Stem Cell 7 (2), 148-149, 2010 | 39 | 2010 |
| A blueprint for translational regenerative medicine JPK Armstrong, TJ Keane, AC Roques, PS Patrick, CM Mooney, WL Kuan, ... Science translational medicine 12 (572), eaaz2253, 2020 | 34 | 2020 |
| The future of cell therapies in the treatment of Parkinson's disease R Laguna Goya, WL Kuan, RA Barker Expert opinion on biological therapy 7 (10), 1487-1498, 2007 | 29 | 2007 |
| Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease WL Kuan, K Stott, X He, TC Wood, S Yang, JCF Kwok, K Hall, Y Zhao, ... Molecular psychiatry 26 (2), 556-567, 2021 | 28 | 2021 |
| Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD) KL Harris, WL Kuan, SL Mason, RA Barker Journal of Neurology, Neurosurgery & Psychiatry 91 (6), 622-630, 2020 | 22 | 2020 |
| Modelling the natural history of Huntington's disease progression WL Kuan, A Kasis, Y Yuan, SL Mason, AS Lazar, RA Barker, J Goncalves Journal of Neurology, Neurosurgery & Psychiatry 86 (10), 1143-1149, 2015 | 18 | 2015 |
